Libor Cervinek

Brno, JM, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Outcomes, Treatment Patterns, and Resource Use in European Adults with Immune Thrombocytopenia Treated with Avatrombopag.

Outcomes, Treatment Patterns, and Resource Use in European Adults with Immune Thrombocytopenia Treated with Avatrombopag.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: January 05, 2026

Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

Journal: The New England journal of medicine

Published: December 09, 2025

Real-World Insights into Avatrombopag's Effectiveness and Safety in Adults with Primary Immune Thrombocytopenia: A Retrospective Analysis from Central and Eastern Europe.

Real-World Insights into Avatrombopag's Effectiveness and Safety in Adults with Primary Immune Thrombocytopenia: A Retrospective Analysis from Central and Eastern Europe.

Journal: Acta haematologica

Published: November 20, 2024

Hypomethylating agents increase L1 retroelement expression without inducing novel insertions in myeloid malignancies.

Hypomethylating agents increase L1 retroelement expression without inducing novel insertions in myeloid malignancies.

Journal: Molecular oncology

Published: July 04, 2024

Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome.

Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome.

Journal: Multidisciplinary respiratory medicine

Published: January 13, 2023

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus.

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus.

Journal: Annals of hematology

Published: November 07, 2022

Ropeginterferon alfa-2 b for the therapy of polycythemia vera.

Ropeginterferon alfa-2 b for the therapy of polycythemia vera.

Journal: Vnitrni lekarstvi

Published: September 18, 2020

Pancytopenia, panhypopituitarism and liver cirrhosis: analysis of a difficult clinical case.

Pancytopenia, panhypopituitarism and liver cirrhosis: analysis of a difficult clinical case.

Journal: Vnitrni lekarstvi

Published: January 08, 2020

Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.

Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.

Journal: Clinical epigenetics

Published: February 25, 2019

Diagnosis and treatment of immune thrombocytopenia.

Diagnosis and treatment of immune thrombocytopenia.

Journal: Vnitrni lekarstvi

Published: September 09, 2018

Efficacy and safety of a new intravenous immunoglobulin (Panzyga® ) in chronic immune thrombocytopenia.

Efficacy and safety of a new intravenous immunoglobulin (Panzyga® ) in chronic immune thrombocytopenia.

Journal: Transfusion medicine (Oxford, England)

Published: December 14, 2017

Sinus histiocytosis with massive lymphadenopathy: FDG-PET/CT documented partial remission after treatment with 2-chlorodeoxyadenosine

Sinus histiocytosis with massive lymphadenopathy: FDG-PET/CT documented partial remission after treatment with 2-chlorodeoxyadenosine

Journal: Vnitrni lekarstvi

Published: August 04, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026